Melanoma Vaccines: The Potential for Clinical Efficacy with Minimal Toxicity in the Adjuvant Setting

By Michael S. Sabel   Vernon K. Sondak  

American Journal of Cancer, Vol. 3, Iss. 6, 2004-01 ,pp. : 377-386

Adis International

Access to resources Recommend Favorite

Cervical Cancer: The Potential Role of Human Papillomavirus (HPV)-Specific Vaccines in Prevention and Treatment

By Schneider A.  

American Journal of Cancer, Vol. 2, Iss. 4, 2003-01 ,pp. : 253-268

Adis International

Access to resources Recommend Favorite

Potential Mouse Tumor Model for Pre-Clinical Testing of Mage -Specific Breast Cancer Vaccines

By Sypniewska R.K.  

Breast Cancer Research and Treatment, Vol. 74, Iss. 3, 2002-08 ,pp. : 221-233

Springer Publishing Company

Access to resources Recommend Favorite

The `peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity

By Graner Michael W.  

International Journal of Hyperthermia, Vol. 29, Iss. 5, 2013-08 ,pp. : 380-389

Informa Healthcare

Access to resources Recommend Favorite

DNA vaccines

By Robinson H.L.   Torres C.A.T.  

Seminars in Immunology, Vol. 9, Iss. 5, 1997-10 ,pp. : 271-283

Academic Press

Access to resources Recommend Favorite